PE20030126A1 - Formulacion pediatrica de gatifloxacina - Google Patents
Formulacion pediatrica de gatifloxacinaInfo
- Publication number
- PE20030126A1 PE20030126A1 PE2002000518A PE2002000518A PE20030126A1 PE 20030126 A1 PE20030126 A1 PE 20030126A1 PE 2002000518 A PE2002000518 A PE 2002000518A PE 2002000518 A PE2002000518 A PE 2002000518A PE 20030126 A1 PE20030126 A1 PE 20030126A1
- Authority
- PE
- Peru
- Prior art keywords
- gatifloxacin
- solution
- acid
- metoxy
- cyclopropyl
- Prior art date
Links
- XUBOMFCQGDBHNK-UHFFFAOYSA-N gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCNC(C)C1 XUBOMFCQGDBHNK-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003923 gatifloxacin Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- 239000002244 precipitate Substances 0.000 abstract 2
- 238000010992 reflux Methods 0.000 abstract 2
- GQYBNVXJQVIRGC-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;hydrochloride Chemical compound Cl.FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCNC(C)C1 GQYBNVXJQVIRGC-UHFFFAOYSA-N 0.000 abstract 1
- -1 3-METHYL-1-PIPERAZINYL Chemical class 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 238000013019 agitation Methods 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000008117 stearic acid Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29962501P | 2001-06-20 | 2001-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030126A1 true PE20030126A1 (es) | 2003-02-08 |
Family
ID=23155586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000518A PE20030126A1 (es) | 2001-06-20 | 2002-06-18 | Formulacion pediatrica de gatifloxacina |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6589955B2 (fr) |
| EP (1) | EP1406572A4 (fr) |
| JP (1) | JP4617475B2 (fr) |
| KR (1) | KR100888519B1 (fr) |
| CN (1) | CN1264514C (fr) |
| AR (1) | AR034483A1 (fr) |
| AU (1) | AU2002345534B2 (fr) |
| BG (1) | BG108444A (fr) |
| BR (1) | BR0209692A (fr) |
| CA (1) | CA2450742A1 (fr) |
| CZ (1) | CZ20033487A3 (fr) |
| EE (1) | EE200400018A (fr) |
| GE (1) | GEP20053610B (fr) |
| HR (1) | HRP20031027A2 (fr) |
| HU (1) | HUP0401497A2 (fr) |
| IL (1) | IL158863A0 (fr) |
| IS (1) | IS7048A (fr) |
| MX (1) | MXPA03011451A (fr) |
| NO (1) | NO20035605D0 (fr) |
| NZ (1) | NZ529611A (fr) |
| PE (1) | PE20030126A1 (fr) |
| PL (1) | PL366559A1 (fr) |
| RU (1) | RU2288218C2 (fr) |
| SK (1) | SK14152003A3 (fr) |
| TW (1) | TWI224004B (fr) |
| UA (1) | UA75656C2 (fr) |
| WO (1) | WO2003000175A2 (fr) |
| YU (1) | YU100303A (fr) |
| ZA (1) | ZA200309173B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1758557B1 (fr) | 2004-05-11 | 2011-07-13 | Egalet Ltd. | Forme galenique gonflant comprenant de la gomme gellane |
| US8546423B2 (en) * | 2005-05-18 | 2013-10-01 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| US7838532B2 (en) * | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| US20070051418A1 (en) * | 2005-09-02 | 2007-03-08 | Rowles Brian A | Multilayer tubes |
| TW201010708A (en) | 2008-06-02 | 2010-03-16 | Intervet Int Bv | Composition comprising an antibiotic and a corticosteroid |
| WO2010042549A1 (fr) | 2008-10-07 | 2010-04-15 | Mpex Pharmaceuticals, Inc. | Inhalation de lévofloxacine pour réduire une inflammation des poumons |
| NZ592717A (en) | 2008-10-07 | 2013-03-28 | Mpex Pharmaceuticals Inc | Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation |
| ES2739979T3 (es) | 2009-09-04 | 2020-02-05 | Horizon Orphan Llc | Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística |
| CN102397546A (zh) * | 2010-09-10 | 2012-04-04 | 广州自远生物科技有限公司 | 一种用于嗅觉或味觉敏感型动物的药物给药方法 |
| CN102397552B (zh) * | 2010-09-10 | 2016-06-08 | 广州自远生物科技有限公司 | 一种含喹诺酮类的药物复合制剂及其制备方法和应用 |
| WO2018129079A1 (fr) * | 2017-01-03 | 2018-07-12 | Thermolife International, Llc | Procédé pour isoler de la théacrine et composition comprenant de la théacrine |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO88836A2 (fr) | 1983-10-11 | 1986-03-31 | Institutul Pentru Controlul De Stat Al Medicamentului Si Cercetari Farmaceutice,Ro | Procede d'obtention des comprimes avec propionate d'erytromycine d'emploi pediatrique |
| JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| NL193682C (nl) | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
| US5405617A (en) | 1991-11-07 | 1995-04-11 | Mcneil-Ppc, Inc. | Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals |
| IT1255792B (it) | 1992-08-05 | 1995-11-16 | Bayer Italia Spa | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda |
| US5407921A (en) | 1993-07-01 | 1995-04-18 | Kao Corporation | Method for suppressing bitter taste |
| JP3449658B2 (ja) | 1994-12-21 | 2003-09-22 | 杏林製薬株式会社 | 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法 |
| DE19633480A1 (de) | 1996-08-20 | 1998-02-26 | Bayer Ag | Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren |
| US5891469A (en) | 1997-04-02 | 1999-04-06 | Pharmos Corporation | Solid Coprecipitates for enhanced bioavailability of lipophilic substances |
| CA2227314A1 (fr) | 1997-01-24 | 1998-07-24 | Hoechst Aktiengesellschaft | Fabrication de preparations a saveur dissimulee contenant des derives de quinolones actifs du point de vue antibacterien |
| GB9702799D0 (en) | 1997-02-12 | 1997-04-02 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms |
| DE19820801A1 (de) * | 1998-05-09 | 1999-11-25 | Gruenenthal Gmbh | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
| CZ302919B6 (cs) | 1999-07-14 | 2012-01-18 | Schering-Plough Ltd. | Vodný farmaceutický prostredek |
-
2002
- 2002-05-09 US US10/143,487 patent/US6589955B2/en not_active Expired - Lifetime
- 2002-05-10 AU AU2002345534A patent/AU2002345534B2/en not_active Ceased
- 2002-05-10 EE EEP200400018A patent/EE200400018A/xx unknown
- 2002-05-10 CA CA002450742A patent/CA2450742A1/fr not_active Abandoned
- 2002-05-10 CN CNB02812409XA patent/CN1264514C/zh not_active Expired - Fee Related
- 2002-05-10 YU YU100303A patent/YU100303A/sh unknown
- 2002-05-10 IL IL15886302A patent/IL158863A0/xx unknown
- 2002-05-10 JP JP2003506621A patent/JP4617475B2/ja not_active Expired - Fee Related
- 2002-05-10 HU HU0401497A patent/HUP0401497A2/hu unknown
- 2002-05-10 NZ NZ529611A patent/NZ529611A/en unknown
- 2002-05-10 PL PL02366559A patent/PL366559A1/xx not_active Application Discontinuation
- 2002-05-10 CZ CZ20033487A patent/CZ20033487A3/cs unknown
- 2002-05-10 GE GE5383A patent/GEP20053610B/en unknown
- 2002-05-10 SK SK1415-2003A patent/SK14152003A3/sk unknown
- 2002-05-10 MX MXPA03011451A patent/MXPA03011451A/es active IP Right Grant
- 2002-05-10 KR KR1020037016647A patent/KR100888519B1/ko not_active IP Right Cessation
- 2002-05-10 EP EP02744141A patent/EP1406572A4/fr not_active Withdrawn
- 2002-05-10 BR BR0209692-7A patent/BR0209692A/pt not_active IP Right Cessation
- 2002-05-10 RU RU2003136068/04A patent/RU2288218C2/ru not_active IP Right Cessation
- 2002-05-10 WO PCT/US2002/014596 patent/WO2003000175A2/fr not_active Application Discontinuation
- 2002-06-13 AR ARP020102227A patent/AR034483A1/es not_active Application Discontinuation
- 2002-06-14 TW TW091113074A patent/TWI224004B/zh not_active IP Right Cessation
- 2002-06-18 PE PE2002000518A patent/PE20030126A1/es not_active Application Discontinuation
- 2002-10-05 UA UA20031211971A patent/UA75656C2/uk unknown
-
2003
- 2003-11-20 IS IS7048A patent/IS7048A/is unknown
- 2003-11-25 ZA ZA200309173A patent/ZA200309173B/en unknown
- 2003-12-10 HR HR20031027A patent/HRP20031027A2/hr not_active Application Discontinuation
- 2003-12-12 BG BG108444A patent/BG108444A/xx unknown
- 2003-12-16 NO NO20035605A patent/NO20035605D0/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030126A1 (es) | Formulacion pediatrica de gatifloxacina | |
| Surrey et al. | Some 7-substituted 4-aminoquinoline derivatives | |
| Kaminsky et al. | Quinoline antibacterial agents. Oxolinic acid and related compounds | |
| DK171330B1 (da) | Pyridoncarboxylsyre-derivater, fremgangsmåde til fremstilling deraf samt antibakterielt farmaceutisk præparat | |
| PE20010904A1 (es) | Cristal de 4-carboxamino-1,2,3,4-tetrahidroquinolina 2-sustituida | |
| KR880001633A (ko) | 7-[[3-(아미노메틸)-3-알킬]-1-피롤리딘일]-퀴놀린-카르복실산 | |
| ZA921268B (en) | 2-substituted quinolines,processes for their preparation and their use in medicaments | |
| LV10254B (en) | Mixture of quinolinecarboxylic acid and boric acid anhydride as intermediate derivatives of piperazinyl-3-quinolincarboxylic acid with antibacterial activity | |
| SU1701110A3 (ru) | Способ получени хинолинкарбоновых кислот или их фармацевтически приемлемых солей | |
| DE3786109D1 (de) | Pyrido(2,3-d)pyrimidin-derivate. | |
| RU2001117521A (ru) | Кристаллическая модификация в 8-циан-1-циклопропил-7-(1s,6s-2,8-диазабицикло[4.3.0]нонан-8-ил)-6-фтор-1, 4-дигидро-4-оксо-3-хинолинкарбоновой кислоты | |
| BRPI0509529B1 (pt) | Forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diaza-biciclo[4.3.0]nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinoli-nocarboxílico, seu uso, e medicamento | |
| JPS63188626A (ja) | ピリドンカルボン酸の可溶化方法 | |
| JPH0215551B2 (fr) | ||
| ATE307583T1 (de) | Wasserfreie kristalline formen i und ii der 1- cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1- piperazinyl) 4-oxo-1, 4-dihydroquinoline-3- carbonsäure (gatifloxacin) | |
| RU2019106531A (ru) | Кристалл соли производного хиназолина | |
| Brain et al. | 75. Derivatives of 6-aminopenicillanic acid. Part IV. Analogues of 2, 6-dimethoxyphenylpenicillin in the naphthalene and quinoline series | |
| JP3381191B2 (ja) | ベンゾ［ｂ］ナフチリジン類の製造方法 | |
| JPH05112554A (ja) | 新規なキノロンカルボン酸誘導体 | |
| Parke et al. | The preparation and properties of sodium d-pantothenate | |
| RU2109014C1 (ru) | Производные фторхинолин-3-карбоновой кислоты и способ их получения | |
| DE3785076T2 (de) | Pyrido(4,3-d)pyrimidin-derivate. | |
| WO1987003586A1 (fr) | Procede pour la preparation de derives de l'acide 1-methylamino-quinoleine-carboxylique | |
| ES2956316T3 (es) | Proceso para la hidrólisis de ésteres carboxílicos de quinolona | |
| US2477049A (en) | Pyridoacridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |